Advertisement

Topics

Anti-Cancer Institute Company Profile

04:25 EST 22nd November 2017 | BioPortfolio


News Articles [3974 Associated News Articles listed on BioPortfolio]

Personal neoantigen vaccine prompts strong anti-tumor response in patients, study shows

(Dana-Farber Cancer Institute) A personal cancer treatment vaccine that targets distinctive 'neoantigens' on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tum...

Study: Personalized neoantigen vaccine stimulates strong anti-tumor response in melanoma patients

A personal cancer treatment vaccine that targets distinctive "neoantigens" on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tumor response in melanoma patient...

Anti-CD47 Antibodies for the Treatment of Cancer

Summary: Researchers at the National Cancer Institute found that CD47 enhances renewal of breast cancer stem cells, and antibody targeting of CD47 forces these stem cells to differentiate.Read more a...

A new approach to cancer drug discovery

(Scripps Research Institute) Scientists at The Scripps Research Institute (TSRI) have developed and demonstrated a promising new strategy for the discovery of novel anti-cancer therapies.

Drug zeroes in on mutated nuclear receptors found in cancer, leaves normal proteins alone

Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have published a study in Nature Communications shedding new light on how K-80003 (TX803), an anti-cancer agent discovered at th...

Novel mechanism of resistance to anti-cancer drugs

The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States. However...

When Two Immunotherapy Rights Make a Wrong

Recent advances in immunotherapy have given many cancer patients stricken with tumors intractable to current therapies hope for meaningful remission times. While researchers continue to try and unders...

Scientists discover new non-genetic cause of resistance to anti-cancer therapies

The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States.

Drugs and Medications [567 Associated Drugs and Medications listed on BioPortfolio]

Halaven [Eisai Inc.]

These highlights do not include all the information needed to use HALAVEN™ safely and effectively. See full prescribing information for HALAVEN. HALAVEN™ (eribulin mesylate) Injection For intraven...

Oral-b neutra-foam mint [Oral-B Laboratories]

Package. Label Principal Display Panel

Ck one waterfresh face makeup spf 15 [Coty US LLC]

Drug Facts

Ck one waterfresh face makeup spf 15 [Coty US LLC]

Drug Facts

Ck one waterfresh face makeup spf 15 [Coty US LLC]

Drug Facts

PubMed Articles [8701 Associated PubMed Articles listed on BioPortfolio]

Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence.

Recent data suggest that the use of nonsteroidal anti-inflammatory drugs (NSAIDs) may be associated with reductions in endometrial cancer risk, yet very few have examined whether their use is related ...

Cell scientist to watch - Paul Timpson.

Paul Timpson received his bachelor's degree from the University of Strathclyde, UK and completed his PhD under the supervision of Margaret Frame at the Beatson Institute for Cancer Research and the Un...

Regional Nodal Irradiation in the Anti-HER2 Era.

US National Cancer Institute-China Collaborative Studies on Chinese Medicine and Cancer.

Since 2007, the US National Cancer Institute (NCI) Office of Cancer Complementary and Alternative Medicine (OCCAM), together with the Cancer Institute of the China Academy of Chinese Medical Sciences ...

In the immuno-oncology era, is anti-PD-1 or anti-PD-L1 immunotherapy modifying the sensitivity to conventional cancer therapies?

The advent of anti-programmed death receptor-1/ligand-1 antibodies (anti-PD(L)1) is profoundly changing the therapeutic strategy of oncology. As anti-PD(L)1 modulate tumour microenvironment, it might ...

Clinical Trials [9852 Associated Clinical Trials listed on BioPortfolio]

Understanding Male Breast Cancer: Salah Azaïz Cancer Institute Experience

The goal of this study is to evaluate the Salah Azaïz Cancer Institute male breast cancer patients population over a period of 14 years. Goal of the retrospective part: to gather clinico...

Bergonie Institute Breast Cancer Database

A database of breast cancer patients was established at Institute Bergonié since the 90s , to assess patients' survival, assess practice, search for prognostic factors.

Cancer in Infants: South Egypt Cancer Institute Experience

The aim of this study is to investigate the spectrum of various types of malignant neoplasms of infancy, according to the experience of South Egypt Cancer Institute, which represents the l...

Addressing Prostate Cancer Information Disparities With eHealth Technology

his is a multicenter study that involves research on screening for prostate cancer. This study pilot tests a culturally appropriate decision aid (DA) for African American (AA) men that wil...

Assessment of a New Fluorescence Imaging Technique Using Biopsies From Prostate Resection

In this study, we aim to evaluate the feasibility of anti-PSMA labelling to detect post-operative prostatic tissues by two ex vivo fluorescence techniques. We will evaluate the feasibility...

Companies [2856 Associated Companies listed on BioPortfolio]

Anti-Cancer Institute

The Barbara Ann Karmanos Cancer Institute

Located in mid-town Detroit, Michigan, the Barbara Ann Karmanos Cancer Institute is one of 40 National Cancer Institute-designated comprehensive cancer centers in the United States. Caring for nearl...

Ovarian Cancer Institute

The Ovarian Cancer Institute is a 501(c)(3) organization dedicated to ovarian cancer research. The work focuses on accurate diagnostics and improved therapeutics. Creators of a fi...

The North Shore-LIJ Cancer Institute

The North Shore-LIJ Cancer Institute is one of the largest cancer providers in the New York metropolitan area. With 200 physicians, the Cancer Institute diagnoses and/or treats mo...

Synergys Biotherapeutics

Synergys is an early stage company developing multifunctional anti-vascularization antibody drugs targeting VEGF-alternative pathways. The Company’s most advanced product can...

More Information about "Anti-Cancer Institute" on BioPortfolio

We have published hundreds of Anti-Cancer Institute news stories on BioPortfolio along with dozens of Anti-Cancer Institute Clinical Trials and PubMed Articles about Anti-Cancer Institute for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Anti-Cancer Institute Companies in our database. You can also find out about relevant Anti-Cancer Institute Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record